-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, UiYIgs9CxCDRDfFCqDP6EUDrbw0PLDxwpqixy+X98+j00R6MROr1AA2fePQq5IzW E4G5sFwNPsGhssHf38rivg== 0000950142-10-000407.txt : 20100310 0000950142-10-000407.hdr.sgml : 20100310 20100310185520 ACCESSION NUMBER: 0000950142-10-000407 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100308 FILED AS OF DATE: 20100310 DATE AS OF CHANGE: 20100310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PERSEUSPUR LLC CENTRAL INDEX KEY: 0001253323 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33719 FILM NUMBER: 10671902 BUSINESS ADDRESS: STREET 1: 2099 PENNSYLVANIA AVE NW STREET 2: STE 900 CITY: WASHINGTON STATE: DC ZIP: 20006-1813 MAIL ADDRESS: STREET 1: 2099 PENNSYLVANIA AVE NW STREET 2: STE 900 CITY: WASHINGTON STATE: DC ZIP: 20006-1813 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAP Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001401923 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200507047 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 2400 BAYSHORE PARKWAY, SUITE 200 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-386-3100 MAIL ADDRESS: STREET 1: 2400 BAYSHORE PARKWAY, SUITE 200 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PEARL FRANK H CENTRAL INDEX KEY: 0000927752 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33719 FILM NUMBER: 10671901 MAIL ADDRESS: STREET 1: 2099 PENNSYLVANIA AVENUE NW STREET 2: SUITE 900 CITY: WASHINGTON STATE: DC ZIP: 20003 4 1 form4_spur030810-mapex.xml FORM 4 X0303 4 2010-03-08 0 0001401923 MAP Pharmaceuticals, Inc. MAPP 0001253323 PERSEUSPUR LLC 2099 PENNSYLVANIA AVE NW STE 900 WASHINGTON DC 20006 0 0 1 0 0000927752 PEARL FRANK H 2099 PENNSYLVANIA AVENUE NW SUITE 900 WASHINGTON DC 20006 0 0 1 0 Common Stock 2010-03-08 4 S 0 5000 14.41 D 2837887 I See Footnote Common Stock 2010-03-09 4 S 0 5000 15.21 D 2832887 I See Footnote Common Stock 2010-03-10 4 S 0 3925 16.04 D 2828962 I See Footnote The price shown in Column 4 is a weighted average sale price. The price range for the sales is $14.25 to $14.59. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. All of the securities reported herein are held for the account of Perseus-Soros BioPharmaceutical Fund, LP ("Perseus-Soros"), Perseus-Soros Partners, LLC ("Perseus-Soros Partners"), the general partner of Perseus-Soros, Perseus Biotech Investment, LLC ("PBI"), Perseus Biotech Fund Partners, LLC ("Perseus Biotech Fund Partners"), Biotech Management Partners, LLC ("Biotech Management Partners"), Perseus, L.L.C. ("Perseus"), Perseuspur, L.L.C. ("Perseuspur"), Perseus 2000 Biotech Satellite, LLC ("Perseus Satellite") and Frank H. Pearl. Perseus BioTech Fund Partners is a managing member of Perseus-Soros Partners and Biotech Management Partners. Perseuspur is the managing member of Perseus, PBI, Perseus Biotech Fund Partners and the entity that controls Perseus Satellite. Frank H. Pearl is the managing member of Perseuspur. Represents 5,000 shares of the Issuer's Common Stock sold by Perseuspur. After the sale, Perseuspur owned directly 8,925 shares of the Issuer's Common Stock. The price shown in Column 4 is a weighted average sale price. The price range for the sales is $15.00 to $15.50. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents 5,000 shares of the Issuer's Common Stock sold by Perseuspur. After the sale, Perseuspur owned directly 3,925 shares of the Issuer's Common Stock. The price shown in Column 4 is a weighted average sale price. The price range for the sales is $15.90 to $16.13. The Reporting Persons undertake to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Represents 3,925 shares of the Issuer's Common Stock sold by Perseuspur. After the sale, Perseuspur owns directly no shares of the Issuer's Common Stock, Perseus owns directly 2,792 shares of the Issuer's Common Stock, Frank H. Pearl owns directly 1 share of the Issuer's Common Stock and Perseus-Soros owns directly 2,826,169 shares of the Issuer's Common Stock. (8) Kenneth M. Socha is signing in his capacity as attorney-in-fact for Mr. Frank H. Pearl, the managing member of Perseuspur. (9) Kenneth M. Socha is signing in his capacity as attorney-in-fact for Mr. Frank H. Pearl. /s/ Kenneth M. Socha (8) 2010-03-10 /s/ Kenneth M. Socha (9) 2010-03-10 EX-99 2 ex99-1_spur.htm EXHIBIT 99.1

Exhibit 99.1

Pursuant to Rule 16a-1(a)(2)(ii)(B) under the Securities Exchange Act of 1934, as amended (the "Act"), Perseuspur or Mr. Pearl may be deemed to be beneficial owners of the shares beneficially owned by Perseus-Soros, Perseus-Soros Partners, Perseus Biotech Fund Partners, Biotech Management Partners, PBI, Perseus, Perseuspur, Perseus Satellite and Frank H. Pearl only to the extent of the greater of his or its respective direct or indirect interest in the profits or capital account of each such person or entity. Pursuant to Rule 16a-1(a)(4) under the Act, this filing shall not be deemed an admission that Perseuspur or Mr. Pearl is for purposes of Section 16 of the Act or otherwise, the beneficial owner of any securities owned by Perseus-Soros, Perseus-Soros Partners, Perseus Biotech Fund Partners, Biotech Management Partners, PBI, Perseus, Perseuspur, Perseus Satellite and Frank H. Pearl in excess of such amount.

-----END PRIVACY-ENHANCED MESSAGE-----